Trastuzumab emtansine in HER2-positive metastatic breast cancer

Research output: Contribution to journalComment/debate

Original languageEnglish
Pages (from-to)696-697
Number of pages2
JournalThe Lancet Oncology
Volume18
Issue number6
DOIs
Publication statusPublished - Jun 1 2017

ASJC Scopus subject areas

  • Oncology

Cite this

Trastuzumab emtansine in HER2-positive metastatic breast cancer. / Montemurro, Filippo.

In: The Lancet Oncology, Vol. 18, No. 6, 01.06.2017, p. 696-697.

Research output: Contribution to journalComment/debate

@article{955402004d5f4a3f9fff88529e47b47a,
title = "Trastuzumab emtansine in HER2-positive metastatic breast cancer",
author = "Filippo Montemurro",
year = "2017",
month = "6",
day = "1",
doi = "10.1016/S1470-2045(17)30303-0",
language = "English",
volume = "18",
pages = "696--697",
journal = "The Lancet Oncology",
issn = "1470-2045",
publisher = "Lancet Publishing Group",
number = "6",

}

TY - JOUR

T1 - Trastuzumab emtansine in HER2-positive metastatic breast cancer

AU - Montemurro, Filippo

PY - 2017/6/1

Y1 - 2017/6/1

UR - http://www.scopus.com/inward/record.url?scp=85020049821&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020049821&partnerID=8YFLogxK

U2 - 10.1016/S1470-2045(17)30303-0

DO - 10.1016/S1470-2045(17)30303-0

M3 - Comment/debate

AN - SCOPUS:85020049821

VL - 18

SP - 696

EP - 697

JO - The Lancet Oncology

JF - The Lancet Oncology

SN - 1470-2045

IS - 6

ER -